Tularemia
暂无分享,去创建一个
Richard W. Titball | R. Titball | P. Oyston | Petra C. F. Oyston | Jill Ellis | Michael Green | J. Ellis | Michael Green
[1] H. Yang,et al. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice , 1997, Antimicrobial agents and chemotherapy.
[2] S. Gedikoğlu,et al. Tularemia in Bursa, Turkey: 205 cases in ten years , 2000, European Journal of Epidemiology.
[3] A. Tärnvik,et al. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium , 1992, Infection and immunity.
[4] D. Malo,et al. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. , 1994, Genomics.
[5] G. Doern. Detection of selected fastidious bacteria. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] A. Fortier,et al. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis , 1993, Infection and immunity.
[7] F. Nano,et al. Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression. , 1994, FEMS microbiology letters.
[8] S. Dolan,et al. Detection of Francisella tularensis in clinical specimens by use of polymerase chain reaction. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] E. Skrodzki. Investigations on the pathogenesis of tularemia. VII. Attempts to discover F.tularensis toxins. , 1968, Biuletyn Instytutu Medycyny Morskiej w Gdansku.
[10] I. Meshcheryakova,et al. Subspecific Taxonomy of Francisella tularensis McCoy and Chapin 1912 , 1983 .
[11] C. Fengxiang,et al. Detection of Francisella tularensis by the polymerase chain reaction. , 1996, Journal of medical microbiology.
[12] P. J. Kadull,et al. Studies on tularemia. V. Immunization of man. , 1950, Journal of immunology.
[13] Philip K. Russell,et al. Tularemia as a biological weapon: medical and public health management. , 2001, JAMA.
[14] A. Tärnvik,et al. Isolation of Francisella tularensis biovar palaearctica from human blood. , 1989, European Journal of Clinical Microbiology and Infectious Diseases.
[15] R. E. Chamberlain,et al. EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM. , 1965, Applied microbiology.
[16] D. Burke. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. , 1977, The Journal of infectious diseases.
[17] Olsufiev Ng,et al. Comparative study of strains of B. tularense in the old and new world and their taxonomy. , 1959 .
[18] A. Tärnvik,et al. Comparative Analysis of PCR versus Culture for Diagnosis of Ulceroglandular Tularemia , 2000, Journal of Clinical Microbiology.
[19] J. W. Conlan,et al. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes , 1992, Infection and immunity.
[20] M. Meltzer,et al. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages. , 1994, Journal of immunology.
[21] I. Golovliov,et al. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein , 1997, Infection and immunity.
[22] G. Sandström,et al. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins , 1996, Infection and immunity.
[23] E. Williams,et al. SEROLOGICAL SURVEY FOR DISEASES IN FREE-RANGING COYOTES (CANIS LATRANS) IN YELLOWSTONE NATIONAL PARK, WYOMING , 1997, Journal of wildlife diseases.
[24] I. Golovliov,et al. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. , 1996, FEMS Immunology & Medical Microbiology.
[25] K. Elkins,et al. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. , 1996, Journal of immunology.
[26] C. E. Hopla. The ecology of tularemia. , 1974, Advances in veterinary science and comparative medicine.
[27] G. Baron,et al. MglA and MglB are required for the intramacrophage growth of Francisella novicida , 1998, Molecular microbiology.
[28] V. M. Sorokin,et al. Francisella tularensis resistance to bactericidal action of normal human serum. , 1996, FEMS immunology and medical microbiology.
[29] W. D. Tigertt. Soviet viable Pasteurella tularensis vaccines. A review of selected articles. , 1962, Bacteriological reviews.
[30] W. R. Griffith,et al. Aerogenic Immunization of the Monkey and Guinea Pig with Live Tularemia Vaccine , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] T. Oetting,et al. Parinaud's oculoglandular syndrome attributable to an encounter with a wild rabbit. , 2001, American journal of ophthalmology.
[32] M. T. Pope,et al. Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils. , 1985, Archives of biochemistry and biophysics.
[33] A. Tärnvik,et al. Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide , 1994, Infection and immunity.
[34] J. Karhukorpi,et al. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. , 2000, The Journal of antimicrobial chemotherapy.
[35] N. Engleberg,et al. Phenotypic modulation by Legionella pneumophila upon infection of macrophages , 1993, Infection and immunity.
[36] R. Pollitzer. History and incidence of tularemia in the Soviet Union : a review , 1967 .
[37] F. Womack,et al. OBSERVATIONS ON THE INFECTION OF CHICK EMBRYOS WITH BACTERIUM TULARENSE, BRUCELLA, AND PASTEURELLA PESTIS , 1941, The Journal of experimental medicine.
[38] A. Tärnvik,et al. Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis , 1987, Journal of clinical microbiology.
[39] James T. Staley,et al. Bergey's Manual of Determinative Bacteriology , 1939 .
[40] R. B. Narayanan,et al. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth , 1995, Infection and immunity.
[41] R. Hornick,et al. Oral tularemia vaccine in man. , 1966, Antimicrobial agents and chemotherapy.
[42] H. Artsob,et al. A serological survey of rural dogs and cats on the southwestern Canadian prairie for zoonotic pathogens. , 2001, Canadian journal of public health = Revue canadienne de sante publique.
[43] P. Koskela,et al. Humoral immunity against Francisella tularensis after natural infection , 1985, Journal of clinical microbiology.
[44] T. Mörner,et al. A serological survey of antibodies against Francisella tularensis in some Swedish mammals. , 1983, Nordisk veterinaermedicin.
[45] A. Sjöstedt,et al. Extensive Allelic Variation among Francisella tularensis Strains in a Short-Sequence Tandem Repeat Region , 2001, Journal of Clinical Microbiology.
[46] A. Sjöstedt,et al. Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan , 1992, Journal of clinical microbiology.
[47] M. Bonneville,et al. Stimulation of gamma delta T cells by phosphoantigens. , 1996, Research in Immunology.
[48] Francisella tularensis does not manifest virulence in viable but non-culturable state. , 2000, FEMS microbiology ecology.
[49] K. Elkins,et al. Minimal requirements for murine resistance to infection with Francisella tularensis LVS , 1996, Infection and immunity.
[50] A. Tärnvik,et al. Epidemiological analysis of tularemia in Sweden 1931-1993. , 1996, FEMS immunology and medical microbiology.
[51] Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. , 1996, FEMS immunology and medical microbiology.
[52] J. Pérez-Castrillón,et al. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] R. Titball,et al. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia. , 1998, The Journal of antimicrobial chemotherapy.
[54] G. C. Klein,et al. Evaluation of a safranin-O-stained antigen microagglutination test for francisella tularensis antibodies , 1980, Journal of clinical microbiology.
[55] R. Burke,et al. Growth of Francisella spp. in rodent macrophages , 1991, Infection and immunity.
[56] R. Titball,et al. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. , 1995, Vaccine.
[57] H. Wilson,et al. Tularemia vaccine study. II. Respiratory challenge. , 1961, Archives of internal medicine.
[58] M. Horwitz,et al. Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. , 1995, The Journal of clinical investigation.
[59] M. Sarvas,et al. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. , 1989, Microbial pathogenesis.
[60] N. G. Olsufjev. Taxonomy and characteristic of the genus Francisella Dorofeev, 1947. , 1970, Journal of hygiene, epidemiology, microbiology, and immunology.
[61] A. Sjöstedt,et al. CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice , 1994, Infection and immunity.
[62] B. Berdal,et al. Field investigations of tularemia in Norway. , 1996, FEMS immunology and medical microbiology.
[63] S. Klotz,et al. Enhancing recovery of Francisella tularensis from blood. , 1988, Diagnostic microbiology and infectious disease.
[64] M. Evans. Francisella tularensis. , 2022, Infection control : IC.
[65] G. Baron,et al. Characterization and Sequencing of a Respiratory Burst-inhibiting Acid Phosphatase from Francisella tularensis(*) , 1996, The Journal of Biological Chemistry.
[66] F. McCrumb,et al. AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS. , 1961, Bacteriological reviews.
[67] A. Tärnvik,et al. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR , 1997, Journal of clinical microbiology.
[68] A. Tärnvik,et al. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. , 1990, Research in microbiology.
[69] A. Sjöstedt,et al. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. , 1994, International journal of systematic bacteriology.
[70] D. McGregor,et al. Tularaemia in the rat. I. The cellular basis on host resistance to infection. , 1975, Immunology.
[71] C. Castell,et al. [Tularemia: report of 16 cases in the Castilla-Leon community]. , 1998, Revista clinica espanola.
[72] M. Forsman,et al. Identification and classification of different isolates of Francisella tularensis. , 1993, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.
[73] A. Tärnvik,et al. Phagocytosis and Killing of Francisella tularensis by Human Polymorphonuclear Leukocytes , 1983, Infection and immunity.
[74] F. Nano,et al. Transformation and allelic replacement in Francisella spp. , 1991, Journal of general microbiology.
[75] F. Neidhardt,et al. Analysis of proteins synthesized by Salmonella typhimurium during growth within a host macrophage , 1993, Journal of bacteriology.
[76] A. Sjöstedt,et al. Ciprofloxacin for treatment of tularemia in children , 2000, The Pediatric infectious disease journal.
[77] A. Tärnvik. Nature of protective immunity to Francisella tularensis. , 1989, Reviews of infectious diseases.
[78] A. Sjöstedt,et al. Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4 , 2001, Journal of applied microbiology.
[79] S. Klotz,et al. Isolation of Francisella tularensis from blood , 1986, Journal of clinical microbiology.
[80] Hans Carlsson,et al. Enzyme-Linked Immunosorbent Assay for Immunological Diagnosis of Human Tularemia , 1979, Journal of clinical microbiology.
[81] A. Natsch,et al. Swiss Army Survey in Switzerland to Determine the Prevalence of Francisella tularensis, Members of the Ehrlichia phagocytophila Genogroup, Borrelia burgdorferi Sensu Lato, and Tick-Borne Encephalitis Virus in Ticks , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[82] D. Guryčová. [Analysis of the incidence and routes of transmission of tularemia in Slovakia]. , 1997, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.
[83] A. Sjöstedt,et al. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. , 1992, FEMS microbiology immunology.
[84] A. Remaley,et al. Characterization of Leishmania donovani acid phosphatases. , 1985, The Journal of biological chemistry.
[85] I. Golovliov,et al. Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. , 1996, FEMS immunology and medical microbiology.
[86] E. Ferri,et al. Comparison of Different PCR Approaches for Typing of Francisella tularensis Strains , 2000, Journal of Clinical Microbiology.
[87] N. G. Olsufiev,et al. Comparative study of strains of B. tularense in the old and new world and their taxonomy. , 1959, Journal of hygiene, epidemiology, microbiology, and immunology.
[88] D. Pombo,et al. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[89] A. Macela,et al. Influence of the Bcg Locus on Natural Resistance to Primary Infection with the Facultative Intracellular Bacterium Francisella tularensis in Mice , 2000, Infection and Immunity.
[90] R. Reintjes,et al. Tularemia Outbreak Investigation in Kosovo: Case Control and Environmental Studies , 2002, Emerging infectious diseases.
[91] R. Jacobs,et al. Tularemia: treatment failures with outpatient use of ceftriaxone. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[92] R. Crawford,et al. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. , 1994, Immunology series.
[93] 広松 賢治. A protective role of γ/δ T cells in primary infection with Listeria monocytogenes in mice , 1993 .
[94] C. Shepard. NONACID-FAST BACTERIA AND HeLa CELLS: THEIR UPTAKE AND SUBSEQUENT INTRACELLULAR GROWTH , 1959, Journal of bacteriology.
[95] A. Tärnvik,et al. Antigenic composition of a vaccine strain of Francisella tularensis. , 1980, International archives of allergy and applied immunology.
[96] A. Tärnvik,et al. Francisella tularensis: host-parasite interaction. , 1996, FEMS immunology and medical microbiology.
[97] L. Foshay,et al. Vaccine Prophylaxis against Tularemia in Man. , 1942, American journal of public health and the nation's health.
[98] F. Nano,et al. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production , 1996, Molecular microbiology.
[99] C. Broome,et al. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. , 1989, Annals of internal medicine.
[100] J. Mathews,et al. Amplification and restriction endonuclease digestion of a large fragment of genes coding for rRNA as a rapid method for discrimination of closely related pathogenic bacteria , 1997, Journal of clinical microbiology.
[101] J. McDonald,et al. Tularemia pneumonia mimicking legionnaires' disease: isolation of organism on CYE agar and successful treatment with erythromycin. , 1983, Southern medical journal (Birmingham, Ala. Print).
[102] R. Hornick,et al. Aerogenic immunization of man with live Tularemia vaccine. , 1966, Bacteriological reviews.
[103] H. Artsob,et al. Seroepidemiologic study of three zoonoses (leptospirosis, Q fever, and tularemia) among trappers in Québec, Canada , 1995, Clinical and diagnostic laboratory immunology.
[104] J. Boyce. Recent trends in the epidemiology of tularemia in the United States. , 1975, The Journal of infectious diseases.
[105] I. Davidsohn. Topley and Wilson's Principles of Bacteriology and Immunity , 1965 .
[106] T. Kupper,et al. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. , 1990, The Journal of investigative dermatology.
[107] R. Titball,et al. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. , 1996, FEMS immunology and medical microbiology.
[108] A. Limaye,et al. Treatment of tularemia with fluoroquinolones: two cases and review. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[109] P. Morrissey,et al. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. , 1992, Journal of immunology.
[110] Z. Hubálek,et al. Detection of Francisella tularensis in infected mammals and vectors using a probe-based polymerase chain reaction. , 2000, The American journal of tropical medicine and hygiene.
[111] D. Guryčová. First isolation of Francisella tularensis subsp. tularensis in Europe , 1998, European Journal of Epidemiology.
[112] A. Tärnvik,et al. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes , 1988, Infection and immunity.
[113] I. Golovliov,et al. Cytokine expression in the liver during the early phase of murine tularemia , 1995, Infection and immunity.
[114] A. Sjöstedt,et al. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection , 1994, Infection and immunity.
[115] P. Kujala,et al. Airborne transmission of tularemia in farmers. , 1985, Scandinavian journal of infectious diseases.
[116] I. Golovliov,et al. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. , 1995, Vaccine.
[117] G. Sandström,et al. Characterization of two unusual clinically significant Francisella strains , 1996, Journal of clinical microbiology.
[118] J. Rosenthal. Oculoglandular tularemia. , 1950, The New Orleans medical and surgical journal.
[119] H. Noda,et al. Endosymbionts of ticks and their relationship to Wolbachia spp. and tick-borne pathogens of humans and animals , 1997, Applied and environmental microbiology.
[120] L. Foshay. A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin. , 1946, The American journal of medicine.
[121] H. Wilson,et al. Tularemia vaccine study. I. Intracutaneous challenge. , 1961, Archives of internal medicine.
[122] M Pallen,et al. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. , 2000, Microbial & comparative genomics.
[123] R. Titball,et al. A rapid, highly sensitive method for the detection of Francisella tularensis in clinical samples using the polymerase chain reaction. , 1996, The American journal of tropical medicine and hygiene.
[124] T. Schwan,et al. Characterization of an endosymbiont infecting wood ticks, Dermacentor andersoni, as a member of the genus Francisella , 1997, Applied and environmental microbiology.
[125] W Schaffner,et al. Tularemia: A 30‐Year Experience With 88 Cases , 1985, Medicine.
[126] Roland Grunow,et al. Detection of Francisella tularensis in Biological Specimens Using a Capture Enzyme-Linked Immunosorbent Assay, an Immunochromatographic Handheld Assay, and a PCR , 2000, Clinical Diagnostic Laboratory Immunology.
[127] B. Nelson,et al. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. , 1994, Immunology letters.
[128] J. P. Pérez Castrillón,et al. [Preliminary report of an epidemic tularemia outbreak in Valladolid]. , 1998, Revista clinica espanola.
[129] M. Homma,et al. Arthropod-borne tularemia in Japan: clinical analysis of 1,374 cases observed between 1924 and 1996. , 1998, Journal of medical entomology.
[130] A. Tärnvik,et al. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals , 1990, Journal of clinical microbiology.
[131] R. Grunow,et al. Field detection of Francisella tularensis. , 2000, Scandinavian journal of infectious diseases.
[132] D. Raoult,et al. Bactericidal Activities of Antibiotics against Intracellular Francisella tularensis , 2000, Antimicrobial Agents and Chemotherapy.
[133] E. Unanue,et al. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli , 1991, Infection and immunity.
[134] Z. Hubálek,et al. Francisella tularensis in Dermacentor reticulatus ticks from the Czech Republic and Austria. , 1998, Wiener klinische Wochenschrift.
[135] A. Fortier,et al. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules , 1992, Infection and immunity.
[136] A. Sjöstedt,et al. Evaluation of PCR-Based Methods for Discrimination ofFrancisella Species and Subspecies and Development of a Specific PCR That Distinguishes the Two Major Subspecies of Francisella tularensis , 2000, Journal of Clinical Microbiology.
[137] E. Francis. Microscopic Changes of Tularaemia in the Tick Dermacentor andersoni and the Bedbug Cimex lectularius. , 1927 .
[138] F. Nano,et al. Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature , 1997, Journal of bacteriology.
[139] H. T. Eigelsbach,et al. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. , 1961, Journal of immunology.
[140] D. Hollis,et al. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth , 1985, Journal of clinical microbiology.
[141] C. W. Moss,et al. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease , 1989, Journal of clinical microbiology.
[142] A. Sjöstedt,et al. Expansion of Vγ9Vδ2 T Cells Is Triggered byFrancisella tularensis-Derived Phosphoantigens in Tularemia but Not after Tularemia Vaccination , 1998, Infection and Immunity.
[143] E. Skamene,et al. Influence of genetic background on host resistance to experimental murine tularemia , 1988, Infection and immunity.
[144] Paul Keim,et al. Francisella tularensis Strain Typing Using Multiple-Locus, Variable-Number Tandem Repeat Analysis , 2001, Journal of Clinical Microbiology.
[145] R. Jacobs,et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[146] I. Golovliov,et al. Francisella tularensis Induces Cytopathogenicity and Apoptosis in Murine Macrophages via a Mechanism That Requires Intracellular Bacterial Multiplication , 2001, Infection and Immunity.
[147] G. Mccoy,et al. Further Observations on a Plague-Like Disease of Rodents with a Preliminary Note on the Causative Agent, Bacterium Tularense , 1912 .